Skip to main content

Advertisement

SpringerLink
Log in

Vascular anomalies of the head and neck: diagnosis and treatment

  • Minisymposium: Pediatric head and neck imaging
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Vascular malformations and vascular tumors comprise the two specific subsets of vascular anomalies that arise as a result of disorganized angiogenesis and neoplasm, respectively. Malformations are separate entities from vascular tumors (e.g., hemangiomas) and are recognized by the International Society for the Study of Vascular Anomalies (ISSVA) as such. Vascular malformations are classified into four main groups: simple, combined, anomalies of major vessels, and those associated with other vascular anomalies. Vascular tumors are neoplastic growths of blood vessels and are morphologically and molecularly distinct from malformations but can arise in the head and neck and have syndromic association. Head and neck vascular anomalies are not uncommon in the pediatric population and require special care in the workup, diagnostic imaging and clinical care. The purpose of this manuscript is to discuss the diagnosis and management of the most common intracranial and extracranial vascular malformations and tumors in the head and neck in children and adolescents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Mulligan PR, Prajapati HJS, Martin LG, Patel TH (2014) Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches. Br J Radiol 87:20130392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Hammill AM, Wentzel M, Gupta A et al (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57:1018–1024

    Article  PubMed  Google Scholar 

  3. Bertino F, Braithwaite KA, Hawkins CM et al (2019) Congenital limb overgrowth syndromes associated with vascular anomalies. Radiographics 39:491–515

    Article  PubMed  Google Scholar 

  4. Hawkins CM, Chewning RH (2019) Diagnosis and management of extracranial vascular malformations in children: arteriovenous malformations, venous malformations, and lymphatic malformations. Semin Roentgenol 54:337–348

    Article  PubMed  Google Scholar 

  5. Kang H-C, Baek ST, Song S, Gleeson JG (2015) Clinical and genetic aspects of the segmental overgrowth spectrum due to somatic mutations in PIK3CA. J Pediatr 167:957–962

    Article  PubMed  Google Scholar 

  6. Jiang B-H, Liu L-Z (2008) PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochem Biophys Acta 1784:150–158

    CAS  PubMed  Google Scholar 

  7. Boscolo E, Coma S, Luks VL et al (2015) AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation. Angiogenesis 18:151–162

    Article  CAS  PubMed  Google Scholar 

  8. Limaye N, Kangas J, Mendola A et al (2015) Somatic activating PIK3CA mutations cause venous malformation. Am J Hum Genet 97:914–921

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Soblet J, Limaye N, Uebelhoer M et al (2013) Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol Syndromol 4:179–183

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wiegand S, Wichmann G, Dietz A (2018) Treatment of lymphatic malformations with the mTOR inhibitor sirolimus: a systematic review. Lymphat Res Biol 16:330–339

    Article  CAS  PubMed  Google Scholar 

  11. Lindhurst MJ, Parker VE, Payne F et al (2012) Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat Genet 44:928–933

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lindhurst MJ, Sapp JC, Teer JK et al (2011) A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 365:611–619

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Keppler-Noreuil KM, Parker VER, Darling TN, Martinez-Agosto JA (2016) Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies. Am J Med Genet C Semin Med Genet 172:402–421

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Keppler-Noreuil KM, Rios JJ, Parker VER et al (2015) PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A 167A:287–295

    Article  PubMed  Google Scholar 

  15. Adams DM, Trenor CC, Hammill AM et al (2016) Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 137:e20153257

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lackner H, Karastaneva A, Schwinger W et al (2015) Sirolimus for the treatment of children with various complicated vascular anomalies. Eur J Pediatr 174:1579–1584

    Article  CAS  PubMed  Google Scholar 

  17. Bertino F, Chaudry G (2019) Overgrowth syndromes associated with vascular anomalies. Semin Roentgenol 54:349–358

    Article  PubMed  Google Scholar 

  18. Darrow DH, Greene AK, Mancini AJ et al (2015) Diagnosis and management of infantile hemangioma: executive summary. Pediatrics 136:786–791

    Article  PubMed  Google Scholar 

  19. Hoff SR, Rastatter JC, Richter GT (2015) Head and neck vascular lesions. Otolaryngol Clin N Am 48:29–45

    Article  Google Scholar 

  20. Siegel DH (2018) PHACE syndrome: infantile hemangiomas associated with multiple congenital anomalies: clues to the cause. Am J Med Genet C Semin Med Genet 178:407–413

    Article  CAS  PubMed  Google Scholar 

  21. Chamli A, Litaiem N (2020) PHACE syndrome. StatPearls. StatPearls Publishing, Treasure Island

  22. Huoh KC, Rosbe KW (2013) Infantile hemangiomas of the head and neck. Pediatr Clin N Am 60:937–949

    Article  Google Scholar 

  23. Badi AN, Kerschner JE, North PE et al (2009) Histopathologic and immunophenotypic profile of subglottic hemangioma: multicenter study. Int J Pediatr Otorhinolaryngol 73:1187–1191

    Article  PubMed  Google Scholar 

  24. North PE, Waner M, Mizeracki A et al (2001) A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 137:559–570

    CAS  PubMed  Google Scholar 

  25. Jarrett DY, Ali M, Chaudry G (2013) Imaging of vascular anomalies. Dermatol Clin 31:251–266

    Article  CAS  PubMed  Google Scholar 

  26. Hyodoh H, Hori M, Akiba H et al (2005) Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues. Radiographics 25:S159–S171

    Article  PubMed  Google Scholar 

  27. Anupindi SA, Biko DM, Ntoulia A et al (2017) Contrast-enhanced US assessment of focal liver lesions in children. Radiographics 37:1632–1647

    Article  PubMed  Google Scholar 

  28. Arnold R, Chaudry G (2011) Diagnostic imaging of vascular anomalies. Clin Plast Surg 38:21–29

    Article  PubMed  Google Scholar 

  29. Flors L, Leiva-Salinas C, Maged IM et al (2011) MR imaging of soft-tissue vascular malformations: diagnosis, classification, and therapy follow-up. Radiographics 31:1321–1340

    Article  PubMed  Google Scholar 

  30. Krishnamurthy R, Bahouth SM, Muthupillai R (2016) 4D contrast-enhanced MR angiography with the keyhole technique in children: technique and clinical applications. Radiographics 36:523–537

    Article  PubMed  Google Scholar 

  31. Burrows PE (2013) Endovascular treatment of slow-flow vascular malformations. Tech Vasc Interv Radiol 16:12–21

    Article  PubMed  Google Scholar 

  32. Albanese G, Kondo KL (2010) Pharmacology of sclerotherapy. Semin Interv Radiol 27:391–399

    Article  Google Scholar 

  33. Chaudry G, Guevara CJ, Rialon KL et al (2014) Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation. Cardiovasc Intervent Radiol 37:1476–1481

    Article  PubMed  Google Scholar 

  34. Vogelzang RL, Atassi R, Vouche M et al (2014) Ethanol embolotherapy of vascular malformations: clinical outcomes at a single center. J Vasc Interv Radiol 25:206–213

    Article  PubMed  Google Scholar 

  35. McAree B, Ikponmwosa A, Brockbank K et al (2012) Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model. Eur J Vasc Endovasc Surg 43:721–725

    Article  CAS  PubMed  Google Scholar 

  36. Lee C-H, Chen S-G (2005) Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck. Br J Plast Surg 58:1073–1078

    Article  PubMed  Google Scholar 

  37. Parsi K (2015) Interaction of detergent sclerosants with cell membranes. Phlebology 30:306–315

    Article  PubMed  Google Scholar 

  38. Jenkinson HA, Wilmas KM, Silapunt S (2017) Sodium tetradecyl sulfate: a review of clinical uses. Dermatol Surg 43:1313–1320

    Article  CAS  PubMed  Google Scholar 

  39. Whiteley MS, Patel SB (2015) Modified Tessari tourbillon technique for making foam sclerotherapy with silicone-free syringes. Phlebology 30:614–617

    Article  PubMed  Google Scholar 

  40. Coleridge Smith P (2005) Saphenous ablation: sclerosant or sclerofoam? Semin Vasc Surg 18:19–24

    Article  PubMed  Google Scholar 

  41. Tisi PV, Beverley C, Rees A (2006) Injection sclerotherapy for varicose veins. Cochrane Database Syst Rev 2006:CD001732

    Google Scholar 

  42. Duffy JP, Hong JC, Farmer DG et al (2009) Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg 208:896–903

    Article  PubMed  Google Scholar 

  43. Goldman MP, Weiss RA, Brody HJ et al (1993) Treatment of facial telangiectasia with sclerotherapy, laser surgery, and/or electrodesiccation: a review. J Dermatol Surg Oncol 19:899–906

    Article  CAS  PubMed  Google Scholar 

  44. Fante RG, Goldman MP (2001) Removal of periocular veins by sclerotherapy. Ophthalmology 108:433–434

    Article  CAS  PubMed  Google Scholar 

  45. Friedmann DP, Goldman MP, Cruz-Inigo AE (2015) Foam sclerotherapy for reticular veins of the chest: a retrospective review of efficacy and safety. Dermatol Surg 41:126–130

    Article  CAS  PubMed  Google Scholar 

  46. Kane WJ, Morris S, Jackson IT, Woods JE (1995) Significant hemangiomas and vascular malformations of the head and neck: clinical management and treatment outcomes. Ann Plast Surg 35:133–143

    Article  CAS  PubMed  Google Scholar 

  47. Minkow B, Laufer D, Gutman D (1979) Treatment of oral hemangiomas with local sclerosing agents. Int J Oral Surg 8:18–21

    Article  CAS  PubMed  Google Scholar 

  48. Agarwal S (2012) Treatment of oral hemangioma with 3% sodium tetradecyl sulfate: study of 20 cases. Indian J Otolaryngol Head Neck Surg 64:205–207

    Article  PubMed  Google Scholar 

  49. Thomas DM, Wieck MM, Grant CN et al (2016) Doxycycline sclerotherapy is superior in the treatment of pediatric lymphatic malformations. J Vasc Interv Radiol 27:1846–1856

    Article  PubMed  Google Scholar 

  50. Alomari AI, Karian VE, Lord DJ et al (2006) Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol 17:1639–1648

    Article  PubMed  Google Scholar 

  51. Farnoosh S, Don D, Koempel J et al (2015) Efficacy of doxycycline and sodium tetradecyl sulfate sclerotherapy in pediatric head and neck lymphatic malformations. Int J Pediatr Otorhinolaryngol 79:883–887

    Article  PubMed  Google Scholar 

  52. Khandpur S, Sharma VK (2010) Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations. Dermatol Surg 36:340–346

    Article  CAS  PubMed  Google Scholar 

  53. Stimpson P, Hewitt R, Barnacle A et al (2012) Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children. Int J Pediatr Otorhinolaryngol 76:569–573

    Article  PubMed  Google Scholar 

  54. Alakailly X, Kummoona R, Quereshy FA et al (2015) The use of sodium tetradecyl sulphate for the treatment of venous malformations of the head and neck. J Maxillofac Oral Surg 14:332–338

    Article  PubMed  Google Scholar 

  55. Cheng J (2015) Doxycycline sclerotherapy in children with head and neck lymphatic malformations. J Pediatr Surg 50:2143–2146

    Article  PubMed  Google Scholar 

  56. Hashimoto N, Phan SH, Imaizumi K et al (2010) Endothelial–mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 43:161–172

    Article  CAS  PubMed  Google Scholar 

  57. Zhang W, Chen G, Ren J-G, Zhao Y-F (2013) Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations. Br J Pharmacol 170:1210–1220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Yang Y, Sun M, Ma Q et al (2011) Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. J Vasc Surg 53:150–155

    Article  PubMed  Google Scholar 

  59. Muir T, Kirsten M, Fourie P et al (2004) Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 19:766–773

    Article  CAS  PubMed  Google Scholar 

  60. Buckmiller LM, Richter GT, Suen JY (2010) Diagnosis and management of hemangiomas and vascular malformations of the head and neck. Oral Dis 16:405–418

    Article  CAS  PubMed  Google Scholar 

  61. Lee BB, Kim DI, Huh S et al (2001) New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg 33:764–772

    Article  CAS  PubMed  Google Scholar 

  62. Mamlouk MD, Lee PW (2018) Developing a multidisciplinary vascular anomalies clinic and reviewing the radiologist’s clinic role. Curr Probl Diagn Radiol 47:378–381

    Article  PubMed  Google Scholar 

  63. Yu Y, Savage RE, Eathiraj S et al (2015) Targeting AKT1-E17K and the PI3K/AKT pathway with an allosteric AKT inhibitor, ARQ 092. PLoS One 10:e0140479

    Article  PubMed  PubMed Central  Google Scholar 

  64. Al-Haddad C, El Salloukh NA, El Moussawi Z (2019) β-Blockers in the treatment of periocular infantile hemangioma. Curr Opin Ophthalmol 30:319–325

    Article  PubMed  Google Scholar 

  65. Sasaki M, North PE, Elsey J et al (2019) Propranolol exhibits activity against hemangiomas independent of beta blockade. NPJ Precis Oncol 3:27

    Article  PubMed  PubMed Central  Google Scholar 

  66. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T et al (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649–2651

    Article  PubMed  Google Scholar 

  67. Durr ML, Meyer AK, Kezirian EJ et al (2017) Sleep-disordered breathing in pediatric head and neck vascular malformations. Laryngoscope 127:2159–2164

    Article  PubMed  Google Scholar 

  68. Ali NJ, Pitson DJ, Stradling JR (1993) Snoring, sleep disturbance, and behaviour in 4-5 year olds. Arch Dis Child 68:360–366

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Lumeng JC, Chervin RD (2008) Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc 5:242–252

    Article  PubMed  PubMed Central  Google Scholar 

  70. Mitchell RB, Call E, Kelly J (2003) Diagnosis and therapy for airway obstruction in children with Down syndrome. Arch Otolaryngol Head Neck Surg 129:642–645

  71. Wang RC, Elkins TP, Keech D et al (1998) Accuracy of clinical evaluation in pediatric obstructive sleep apnea. Otolaryngol Head Neck Surg 118:69–73

    Article  CAS  PubMed  Google Scholar 

  72. Jolink F, van Steenwijk RP, van der Horst CM (2015) Consider obstructive sleep apnea in patients with oropharyngeal vascular malformations. J Craniomaxillofac Surg 43:1937–1941

    Article  CAS  PubMed  Google Scholar 

  73. Siniluoto TMJ, Svendsen PA, Wikholm GM et al (1997) Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (Sotradecol). Scand J Plast Reconstr Surg Hand Surg 31:145–150

    Article  CAS  PubMed  Google Scholar 

  74. Griffiths B, Lee G, Durward A (2017) Critical airway obstruction in apparently asymptomatic neonates. Pediatr Pulmonol 52:E15–E17

    Article  PubMed  Google Scholar 

  75. Chua A-P, Senthilvel E, Hawley K et al (2011) Congenital cervicofacial venous and lymphatic malformations causing severe obstructive sleep apnea — a report of 2 pediatric cases and review of the literature. Int J Pediatr Otorhinolaryngol Extra 6:211–214

    Article  Google Scholar 

  76. Ramar K, Kasperbauer JL, Olson EJ (2008) Use of continuous positive airway pressure to treat obstructive sleep apnea with an orofacial vascular malformation and bilateral tonsillar enlargement. Sleep Med 9:587–588

    Article  PubMed  Google Scholar 

  77. Kimura K, Adlakha A, Staats BA, Shepard JW (1999) Successful treatment of obstructive sleep apnea with use of nasal continuous positive airway pressure in three patients with mucosal hemangiomas of the oral cavity. Mayo Clin Proc 74:155–158

    Article  CAS  PubMed  Google Scholar 

  78. Scherer K, Waner M (2007) Nd:YAG lasers (1,064 nm) in the treatment of venous malformations of the face and neck: challenges and benefits. Lasers Med Sci 22:119–126

    Article  PubMed  Google Scholar 

  79. Crockett DJ, Meier JD, Wilson KF, Grimmer JF (2013) Treatment of oral cavity venous malformations with the Nd:YAG laser using the underwater technique. Otolaryngol Neck Surg 149:954–956

    Article  Google Scholar 

  80. Hartmann F, Lockmann A, Grönemeyer L-L et al (2017) Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children. J Eur Acad Dermatol Venereol 31:1372–1379

    Article  CAS  PubMed  Google Scholar 

  81. Kohout MP, Hansen M, Pribaz JJ, Mulliken JB (1998) Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg 102:643–654

    Article  CAS  PubMed  Google Scholar 

  82. Park KB, Do YS, Kim D-I et al (2012) Predictive factors for response of peripheral arteriovenous malformations to embolization therapy: analysis of clinical data and imaging findings. J Vasc Interv Radiol 23:1478–1486

    Article  PubMed  Google Scholar 

  83. Spetzler RF, Martin NA (1986) A proposed grading system for arteriovenous malformations. J Neurosurg 65:476–483

    Article  CAS  PubMed  Google Scholar 

  84. Cahill AM, Nijs ELF (2011) Pediatric vascular malformations: pathophysiology, diagnosis, and the role of interventional radiology. Cardiovasc Intervent Radiol 34:691–704

    Article  PubMed  Google Scholar 

  85. Nosher JL, Murillo PG, Liszewski M et al (2014) Vascular anomalies: a pictorial review of nomenclature, diagnosis and treatment. World J Radiol 6:677–692

    Article  PubMed  PubMed Central  Google Scholar 

  86. Amyere M, Boon LM, Vikkula M (2017) Genetics of arteriovenous malformations. In: Beneš V, Bradáč O (eds) Brain arteriovenous malformations: pathogenesis, epidemiology, diagnosis, treatment and outcome. Springer International Publishing, Cham, pp 23–36

    Chapter  Google Scholar 

  87. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18:1926–1945

    Article  CAS  PubMed  Google Scholar 

  88. Lee D-F, Hung M-C (2007) All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle 6:3011–3014

    Article  CAS  PubMed  Google Scholar 

  89. Couto JA, Huang AY, Konczyk DJ et al (2017) Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation. Am J Hum Genet 100:546–554

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Wei T, Zhang H, Cetin N et al (2016) Elevated expression of matrix metalloproteinase-9 not matrix metalloproteinase-2 contributes to progression of extracranial arteriovenous malformation. Sci Rep 6:24378

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Sandalcioglu IE, Asgari S, Wende D et al (2010) Proliferation activity is significantly elevated in partially embolized cerebral arteriovenous malformations. Cerebrovasc Dis 30:396–401

    Article  PubMed  Google Scholar 

  92. Yakes WF (2004) Endovascular management of high-flow arteriovenous malformations. Semin Interv Radiol 21:49–58

    Article  Google Scholar 

  93. Alomari A, Dubois J (2011) Interventional management of vascular malformations. Tech Vasc Interv Radiol 14:22–31

    Article  PubMed  Google Scholar 

  94. Jin Y, Zou Y, Hua C et al (2017) Treatment of early-stage extracranial arteriovenous malformations with intralesional interstitial bleomycin injection: a pilot study. Radiology 287:194–204

    Article  PubMed  Google Scholar 

  95. Burch EA, Orbach DB (2015) Pediatric central nervous system vascular malformations. Pediatr Radiol 45:463–472

    Article  Google Scholar 

  96. Fullerton HJ, Achrol AS, Johnston SC et al (2005) Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke 36:2099–2104

    Article  PubMed  Google Scholar 

  97. van Rooij WJ, Sluzewski M, Beute GN (2007) Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 28:172–177

    PubMed  PubMed Central  Google Scholar 

  98. Jahan R, Murayama Y, Gobin YP et al (2001) Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 48:984–997

    CAS  PubMed  Google Scholar 

  99. Pierot L, Januel AC, Herbreteau D et al (2005) Endovascular treatment of brain arteriovenous malformations using Onyx: preliminary results of a prospective multicenter study. Interv Neuroradiol 11:159–164

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Szajner M, Roman T, Markowicz J, Szczerbo-Trojanowska M (2013) Onyx in endovascular treatment of cerebral arteriovenous malformations — a review. Pol J Radiol 78:35–41

    Article  PubMed  PubMed Central  Google Scholar 

  101. Weber W, Kis B, Siekmann R et al (2007) Preoperative embolization of intracranial arteriovenous malformations with Onyx. Neurosurgery 61:244–254

    Article  PubMed  Google Scholar 

  102. Hasegawa H, Yamamoto M, Shin M, Barfod BE (2019) Gamma knife radiosurgery for brain vascular malformations: current evidence and future tasks. Ther Clin Risk Manag 15:1351–1367

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Tsai L-K, Liu H-M, Jeng J-S (2016) Diagnosis and management of intracranial dural arteriovenous fistulas. Expert Rev Neurother 16:307–318

    Article  CAS  PubMed  Google Scholar 

  104. Guedin P, Gaillard S, Boulin A et al (2010) Therapeutic management of intracranial dural arteriovenous shunts with leptomeningeal venous drainage: report of 53 consecutive patients with emphasis on transarterial embolization with acrylic glue. J Neurosurg 112:603–610

    Article  PubMed  Google Scholar 

  105. De Keukeleire K, Vanlangenhove P, Kalala Okito J-P et al (2011) Transarterial embolization with ONYX for treatment of intracranial non-cavernous dural arteriovenous fistula with or without cortical venous reflux. J Neurointerv Surg 3:224–228

    Article  PubMed  Google Scholar 

  106. Lasjaunias P (1997) Vascular diseases in neonates, infants and children: interventional neuroradiology management. Springer-Verlag, Berlin

    Book  Google Scholar 

  107. Berenstein A, Paramasivam S, Sorscher M et al (2019) Vein of Galen aneurysmal malformation: advances in management and endovascular treatment. Neurosurgery 84:469–478

    Article  PubMed  Google Scholar 

  108. Duran D, Karschnia P, Gaillard JR et al (2018) Human genetics and molecular mechanisms of vein of Galen malformation. J Neurosurg Pediatr 21:367–374

    Article  PubMed  Google Scholar 

  109. Li A-H, Armstrong D, terBrugge KG (2011) Endovascular treatment of vein of Galen aneurysmal malformation: management strategy and 21-year experience in Toronto. J Neurosurg Pediatr 7:3–10

    Article  PubMed  Google Scholar 

  110. Revencu N, Boon LM, Mulliken JB et al (2008) Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat 29:959–965

    Article  CAS  PubMed  Google Scholar 

  111. Merrow AC, Gupta A, Patel MN, Adams DM (2016) 2014 revised classification of vascular lesions from the International Society for the Study of Vascular Anomalies: radiologic-pathologic update. Radiographics 36:1494–1516

    Article  PubMed  Google Scholar 

  112. Mahajan P, Margolin J, Iacobas I (2017) Kasabach-Merritt phenomenon: classic presentation and management options. Clin med insights. Blood Disord 10:1179545X17699849

  113. Hall GW (2001) Kasabach–Merritt syndrome: pathogenesis and management. Br J Haematol 112:851–862

    Article  CAS  PubMed  Google Scholar 

  114. Kim JS, Chandler A, Borzykowski R et al (2012) Maximizing time-resolved MRA for differentiation of hemangiomas, vascular malformations and vascularized tumors. Pediatr Radiol 42:775–784

    Article  PubMed  Google Scholar 

  115. Bhat V, Salins PC, Bhat V (2014) Imaging spectrum of hemangioma and vascular malformations of the head and neck in children and adolescents. J Clin Imaging Sci 4:31

    Article  PubMed  PubMed Central  Google Scholar 

  116. Baer AH, Parmar HA, DiPietro MA et al (2011) Hemangiomas and vascular malformations of the head and neck: a simplified approach. Neuroimaging Clin N Am 21:641–658

    Article  PubMed  Google Scholar 

  117. Chewning RH, Monroe EJ, Lindberg A et al (2018) Combined glue embolization and excision for the treatment of venous malformations. CVIR Endovasc 1:22

    Article  PubMed  PubMed Central  Google Scholar 

  118. Lally SE (2016) Update on orbital lymphatic malformations. Curr Opin Ophthalmol 27:413–415

    Article  PubMed  Google Scholar 

  119. Nassiri N, Rootman J, Rootman DB, Goldberg RA (2015) Orbital lymphaticovenous malformations: current and future treatments. Surv Ophthalmol 60:383–405

    Article  PubMed  Google Scholar 

  120. Poonyathalang A, Preechawat P, Jiarakongmun P, Pongpech S (2008) Sclerosing therapy for orbital lymphangioma using sodium tetradecyl sulfate. Jpn J Ophthalmol 52:298–304

    Article  CAS  PubMed  Google Scholar 

  121. Alqahtani A, Nguyen LT, Flageole H et al (1999) 25 years’ experience with lymphangiomas in children. J Pediatr Surg 34:1164–1168

  122. Castillo SD, Vanhaesebroeck B, Sebire NJ (2016) Phosphoinositide 3-kinase: a new kid on the block in vascular anomalies. J Pathol 240:387–396

    Article  CAS  PubMed  Google Scholar 

  123. Zhang L, Zhou F, Han W et al (2010) VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res 20:1319–1331

    Article  CAS  PubMed  Google Scholar 

  124. Flores-Terry M, Zamberk-Majlis P, Cortina-de la Calle MP, García-Arpa M (2018) Síndrome de CLAPO [CLAPO syndrome]. Actas Dermo-Sifiliográficas 109:180

    Article  CAS  PubMed  Google Scholar 

  125. Chapas AM, Eickhorst K, Geronemus RG (2007) Efficacy of early treatment of facial port wine stains in newborns: a review of 49 cases. Lasers Surg Med 39:563–568

    Article  PubMed  Google Scholar 

  126. Nguyen CM, Yohn JJ, Huff C et al (1998) Facial port wine stains in childhood: prediction of the rate of improvement as a function of the age of the patient, size and location of the port wine stain and the number of treatments with the pulsed dye (585 nm) laser. Br J Dermatol 138:821–825

    Article  CAS  PubMed  Google Scholar 

  127. Nelson JS, Jia W, Phung TL, Mihm MC (2011) Observations on enhanced port wine stain blanching induced by combined pulsed dye laser and rapamycin administration. Lasers Surg Med 43:939–942

    Article  PubMed  PubMed Central  Google Scholar 

  128. Marqués L, Núñez-Córdoba JM, Aguado L et al (2015) Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial. J Am Acad Dermatol 72:151–158.e1

  129. Ortiz AE, Nelson JS (2012) Port-wine stain laser treatments and novel approaches. Facial Plast Surg 28:611–620

    Article  CAS  PubMed  Google Scholar 

  130. Plasencia AR, Santillan A (2014) Giant arteriovenous fistula in Parkes Weber syndrome. J Vasc Surg 60:233

    Article  PubMed  Google Scholar 

  131. Manresa-Manresa F, Iribarren-Marín MA, Gómez-Ruiz FT (2015) Parkes-Weber syndrome. Rev Espanola Cardiol Engl Ed 68:67

    Article  Google Scholar 

  132. Girón-Vallejo O, López-Gutiérrez JC, Fernández-Pineda I (2013) Diagnosis and treatment of Parkes Weber syndrome: a review of 10 consecutive patients. Ann Vasc Surg 27:820–825

    Article  PubMed  Google Scholar 

  133. Alomari AI, Chaudry G, Rodesch G et al (2011) Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patients. AJNR Am J Neuroradiol 32:1812–1817

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Kurek KC, Luks VL, Ayturk UM et al (2012) Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 90:1108–1115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Mirzaa GM, Rivière J-B, Dobyns WB (2013) Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet 163:122–130

    Article  CAS  Google Scholar 

  136. Mirzaa GM, Conway RL, Gripp KW et al (2012) Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A 158A:269–291

    Article  PubMed  Google Scholar 

  137. Rodriguez-Laguna L, Ibañez K, Gordo G et al (2018) CLAPO syndrome: identification of somatic activating PIK3CA mutations and delineation of the natural history and phenotype. Genet Med 20:882–889

    Article  CAS  PubMed  Google Scholar 

  138. Higueros E, Roe E, Granell E, Baselga E (2017) Sturge-Weber syndrome: a review. Actas Dermo-Sifiliográficas Engl Ed 108:407–417

    Article  CAS  Google Scholar 

  139. Sundaram SK, Michelhaugh SK, Klinger NV et al (2017) GNAQ mutation in the venous vascular malformation and underlying brain tissue in Sturge–Weber syndrome. Neuropediatrics 48:385–389

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  140. Shirley MD, Tang H, Gallione CJ et al (2013) Sturge–Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 368:1971–1979

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  141. Comi AM (2003) Pathophysiology of Sturge-Weber syndrome. J Child Neurol 18:509–516

    Article  PubMed  Google Scholar 

  142. Maiuri F, Gangemi M, Iaconetta G, Maiuri L (1989) Sturge-Weber disease without facial versus. J Neurosurg Sci 33:215–218

    CAS  PubMed  Google Scholar 

  143. Silverstein M, Salvin J (2019) Ocular manifestations of Sturge–Weber syndrome. Curr Opin Ophthalmol 30:301–305

    Article  PubMed  Google Scholar 

  144. Bajaj Y, Kapoor K, Ifeacho S et al (2013) Great Ormond Street Hospital treatment guidelines for use of propranolol in infantile isolated subglottic haemangioma. J Laryngol Otol 127:295–298

    Article  CAS  PubMed  Google Scholar 

  145. Kralik SF, Haider KM, Lobo RR et al (2018) Orbital infantile hemangioma and rhabdomyosarcoma in children: differentiation using diffusion-weighted magnetic resonance imaging. J Am Assoc Pediatr Ophthalmol Strabismus 22:27–31

    Article  Google Scholar 

  146. Horii KA, Drolet BA, Frieden IJ et al (2011) Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol 28:245–253

    Article  PubMed  Google Scholar 

  147. Huang SA, Tu HM, Harney JW et al (2000) Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 343:185–189

    Article  CAS  PubMed  Google Scholar 

  148. Krol A, MacArthur CJ (2005) Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas. Arch Facial Plast Surg 7:307–311

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology and Imaging Sciences, Emory University School of Medicine, 1364 Clifton Road NE, Room BG03, Atlanta, GA, 30322, USA

    Frederic Bertino, Anna V. Trofimova, Shenise N. Gilyard & C. Matthew Hawkins

  2. Division of Pediatric Radiology, Division of Interventional Radiology and Image Guided Medicine, Children’s Healthcare of Atlanta, Emory + Children’s Pediatric Institute, Atlanta, GA, USA

    C. Matthew Hawkins

Authors
  1. Frederic Bertino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna V. Trofimova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shenise N. Gilyard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Matthew Hawkins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frederic Bertino.

Ethics declarations

Conflicts of interest

None

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bertino, F., Trofimova, A.V., Gilyard, S.N. et al. Vascular anomalies of the head and neck: diagnosis and treatment. Pediatr Radiol 51, 1162–1184 (2021). https://doi.org/10.1007/s00247-021-04968-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-021-04968-2

Keywords

Search

Navigation